These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22073272)

  • 1. Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
    Kus V; Flachs P; Kuda O; Bardova K; Janovska P; Svobodova M; Jilkova ZM; Rossmeisl M; Wang-Sattler R; Yu Z; Illig T; Kopecky J
    PLoS One; 2011; 6(11):e27126. PubMed ID: 22073272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.
    Horakova O; Medrikova D; van Schothorst EM; Bunschoten A; Flachs P; Kus V; Kuda O; Bardova K; Janovska P; Hensler M; Rossmeisl M; Wang-Sattler R; Prehn C; Adamski J; Illig T; Keijer J; Kopecky J
    PLoS One; 2012; 7(8):e43764. PubMed ID: 22952760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.
    Kuda O; Jelenik T; Jilkova Z; Flachs P; Rossmeisl M; Hensler M; Kazdova L; Ogston N; Baranowski M; Gorski J; Janovska P; Kus V; Polak J; Mohamed-Ali V; Burcelin R; Cinti S; Bryhn M; Kopecky J
    Diabetologia; 2009 May; 52(5):941-51. PubMed ID: 19277604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids.
    Flachs P; Rühl R; Hensler M; Janovska P; Zouhar P; Kus V; Macek Jilkova Z; Papp E; Kuda O; Svobodova M; Rossmeisl M; Tsenov G; Mohamed-Ali V; Kopecky J
    Diabetologia; 2011 Oct; 54(10):2626-38. PubMed ID: 21779874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue.
    Bardova K; Funda J; Pohl R; Cajka T; Hensler M; Kuda O; Janovska P; Adamcova K; Irodenko I; Lenkova L; Zouhar P; Horakova O; Flachs P; Rossmeisl M; Colca J; Kopecky J
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice.
    Jilkova ZM; Hensler M; Medrikova D; Janovska P; Horakova O; Rossmeisl M; Flachs P; Sell H; Eckel J; Kopecky J
    Int J Obes (Lond); 2014 Feb; 38(2):216-23. PubMed ID: 23756677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition.
    Pavlisova J; Bardova K; Stankova B; Tvrzicka E; Kopecky J; Rossmeisl M
    Biochimie; 2016 May; 124():150-162. PubMed ID: 26151346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.
    Villarroya J; Flachs P; Redondo-Angulo I; Giralt M; Medrikova D; Villarroya F; Kopecky J; Planavila A
    Lipids; 2014 Nov; 49(11):1081-9. PubMed ID: 25204579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.
    Jelenik T; Rossmeisl M; Kuda O; Jilkova ZM; Medrikova D; Kus V; Hensler M; Janovska P; Miksik I; Baranowski M; Gorski J; Hébrard S; Jensen TE; Flachs P; Hawley S; Viollet B; Kopecky J
    Diabetes; 2010 Nov; 59(11):2737-46. PubMed ID: 20693347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice.
    Hensler M; Bardova K; Jilkova ZM; Wahli W; Meztger D; Chambon P; Kopecky J; Flachs P
    Lipids Health Dis; 2011 Aug; 10():128. PubMed ID: 21810216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients.
    Rossmeisl M; Pavlisova J; Janovska P; Kuda O; Bardova K; Hansikova J; Svobodova M; Oseeva M; Veleba J; Kopecky J; Zacek P; Fiserova E; Pelikanova T; Kopecky J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):712-725. PubMed ID: 29626526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
    Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
    J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids.
    Yang ZH; Inoue S; Taniguchi Y; Miyahara H; Iwasaki Y; Takeo J; Sakaue H; Nakaya Y
    Lipids Health Dis; 2015 Dec; 14():155. PubMed ID: 26627187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma levels of palmitoleic acid may contribute to beneficial effects of Krill oil on glucose homeostasis in dietary obese mice.
    Rossmeisl M; Pavlisova J; Bardova K; Kalendova V; Buresova J; Kuda O; Kroupova P; Stankova B; Tvrzicka E; Fiserova E; Horakova O; Kopecky J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158732. PubMed ID: 32371092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.
    Rossmeisl M; Jilkova ZM; Kuda O; Jelenik T; Medrikova D; Stankova B; Kristinsson B; Haraldsson GG; Svensen H; Stoknes I; Sjövall P; Magnusson Y; Balvers MG; Verhoeckx KC; Tvrzicka E; Bryhn M; Kopecky J
    PLoS One; 2012; 7(6):e38834. PubMed ID: 22701720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants.
    Djaouti L; Jourdan T; Demizieux L; Chevrot M; Gresti J; Vergès B; Degrace P
    Diabetes Metab Res Rev; 2010 May; 26(4):297-305. PubMed ID: 20503262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis.
    Janovská P; Flachs P; Kazdová L; Kopecký J
    Physiol Res; 2013; 62(2):153-61. PubMed ID: 23234412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice.
    Pavlisova J; Horakova O; Kalendova V; Buresova J; Bardova K; Holendova B; Plecita-Hlavata L; Vackova S; Windrichova J; Topolcan O; Kopecky J; Rossmeisl M
    Food Funct; 2020 Nov; 11(11):9764-9775. PubMed ID: 33078809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
    Deeg MA; Buse JB; Goldberg RB; Kendall DM; Zagar AJ; Jacober SJ; Khan MA; Perez AT; Tan MH;
    Diabetes Care; 2007 Oct; 30(10):2458-64. PubMed ID: 17595355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.